The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Further evaluations of nivolumab (nivo) versus investigator’s choice (IC) chemotherapy for recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): CheckMate 141.
 
Robert L. Ferris
No Relationships to Disclose
 
George R. Blumenschein
No Relationships to Disclose
 
Jerome Fayette
No Relationships to Disclose
 
Joel Guigay
No Relationships to Disclose
 
A. Dimitrios Colevas
No Relationships to Disclose
 
Lisa F. Licitra
No Relationships to Disclose
 
Kevin J. Harrington
No Relationships to Disclose
 
Stefan Kasper
No Relationships to Disclose
 
Everett E. Vokes
No Relationships to Disclose
 
Caroline Even
No Relationships to Disclose
 
Francis P. Worden
No Relationships to Disclose
 
Robert I. Haddad
No Relationships to Disclose
 
Naomi Kiyota
No Relationships to Disclose
 
Makoto Tahara
No Relationships to Disclose
 
Manish Monga
No Relationships to Disclose
 
Mark John Lynch
No Relationships to Disclose
 
William J. Geese
No Relationships to Disclose
 
Justin Kopit
No Relationships to Disclose
 
James W Shaw
No Relationships to Disclose
 
Maura L. Gillison
No Relationships to Disclose